Viking Global Investors LP Pmv Pharmaceuticals, Inc. Transaction History

Viking Global Investors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$9.23 - $22.43 $9.93 Million - $24.1 Million	-1,076,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$14.86 - $23.55 $10.6 Million - $16.8 Million	-714,284 Reduced 39.9%	1,076,000 $22.4 Million
Q2 2021 Aug 16, 2021	SELL	$28.01 - $36.01 $8.29 Million - $10.7 Million	-296,000 Reduced 14.19%	1,790,284 $61.2 Million
Q1 2021 May 17, 2021	SELL	$30.66 - $49.5 $8.52 Million - $13.8 Million	-277,778 Reduced 11.75%	2,086,284 $68.6 Million
Q4 2020 Feb 16, 2021	SELL	$31.86 - $61.51 $8.85 Million - $17.1 Million	-277,778 Reduced 10.51%	2,364,062 $145 Million
Q3 2020 Nov 16, 2020	BUY	$35.5 - $38.0 $93.8 Million - $100 Million	2,641,840 New	2,641,840 $93.8 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

Stay updated on Viking Global Investors LP with notifications on news.